Combined sales of Type 2 diabetes treatments Januvia and Janumet declined 12%. "Merck Revenue and Profit Falls -- Update," published at 12:38 p.m. EST, incorrectly stated that Januvia sales alone declined 12% in the eighth paragraph. The error also appeared in an earlier version of the story published at 7:51 a.m. EST

(END) Dow Jones Newswires

February 03, 2016 15:54 ET (20:54 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Merck Charts.